A Phase 2 interventional study of ACTIQ (Oral Transmucosal Fentanyl Citrate [OTFC]) in Pain, Cancer and Sickle Cell Anemia, sponsored by Cephalon. Completed at 28 sites in 3 countries. Open to participants aged 3 Years to 15 Years. Per ClinicalTrials.gov, last updated 2014-05-09.
Sponsored by Cephalon (part of Teva Pharmaceutical Industries, Ltd.) · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 72 studies testing fentanyl in Pain — 4 open to participants now, 4 under way, none of them phase 3. Fentanyl · Pain.
Among the 72 studies testing fentanyl in Pain, this one is one of 9 that started in 2006, is one of 6 in phase 2, and was the 2nd registered.
10,075 studies on the registry are indexed under Pain; 1,649 are open to participants now.
Browse Pain studies →4 of the 72 studies testing fentanyl in Pain are open now, in 2 countries. Recruiting first, the newest first:
Duke University · Sites in United States
Ages 6 mo–4 yrs
Antonios Likourezos · Sites in United States
Ages 18–120
Hepatopancreatobiliary Surgery Institute of Gansu Province · Sites in China
Ages 18–75
Cedars-Sinai Medical Center · Sites in United States
Ages 18–80 · Healthy volunteers
By country, each count listing its studies:
Fentanyl: first FDA approval 1968 (SUBLIMAZE PRESERVATIVE FREE), first EMA approval 2006. What it is approved for, and how studies give it, is on its page →
Of the 929 Pain studies recruiting now, 384 (41%) set no upper age limit and 433 (47%) stop at 75 or younger; 145 take children under 18; 220 take healthy volunteers.
This study: 3 Years to 15 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
72 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 10 · Phase 2 11 · Phase 3 22 · Phase 4 24
First in 2002; this study’s year is marked. 9 started in 2006.
By drug class, each counting the studies that test any of its medicines:
Median enrollment 62 across the 70 interventional studies. Of the 60 that completed or were terminated, 18 (30%) have results posted.
This tab as a report to print or save as PDF → With an account.
18 of 72 have an industry lead sponsor. The 10 most frequent:
This study is registered under Cephalon, one of the names counted as Teva Pharmaceutical Industries, Ltd.. Under that name alone:
Cephalon is the lead sponsor of 75 studies on the registry; none are open to participants now.
11 studies in Pain by Teva Pharmaceutical Industries, Ltd.: none open now, none under way, none of them phase 3. Of 11 finished, 2 (18%) have results posted.
Among the 11 studies in Pain by Teva Pharmaceutical Industries, Ltd., this one is one of 3 that started in 2006, is the only one in phase 2, and was the 4th registered.
Teva Pharmaceutical Industries, Ltd.’s Pain studies by the year they started, since 2004.
2 of the studies testing fentanyl in Pain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06962306Duke UniversityOptimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery | 2027-06-04 |
| NCT06364540Antonios LikourezosNebulized Ketamine to Nebulized Fentanyl for Treating Acute Painful Conditions in the ED | 2027-06-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 72 studies testing fentanyl in Pain, from their registry updates:
Nothing recorded among them since 2026-09-25.
Among Teva Pharmaceutical Industries, Ltd.’s 11 in Pain:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The objective of the study is to monitor the safety (adverse event data) of longer-term use of ACTIQ (Oral Transmucosal Fentanyl Citrate [OTFC]) treatment in children with pain associated with cancer, sickle cell disease, or severe burns and breakthrough pain (BTP) who are receiving around the clock (ATC) opioid therapy.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Children are included in the study if all of the following criteria are met:
The child must be experiencing episodes of BTP (defined as transient flares of pain that require a bolus of medication as treatment) as follows:
Exclusion Criteria:
Children are excluded from participating in this study if 1 or more of the following criteria are met:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Childbearing potential
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The objective of the study is to monitor the safety (adverse event data) of longer-term use of ACTIQ treatment in children with pain and BTP who are receiving ATC opioid therapy.
The record gives a start of Oct 2006 and a primary completion of Dec 2006. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Fentanyl